Public Section Preview
Microbes and Fermentation
6.1 Classification of Microbes
| Type | Cell type | Examples | Role |
|---|---|---|---|
| Bacteria | Prokaryote | Lactobacillus, E. coli, Rhizobium, Mycobacterium | Curd, nitrogen fixation, disease, industrial |
| Fungi | Eukaryote | Saccharomyces (yeast), Penicillium, Aspergillus | Fermentation, antibiotics, enzymes |
| Algae | Eukaryote | Chlorella, Anabaena (cyanobacteria) | O₂ production, nitrogen fixation, food |
| Protozoa | Eukaryote | Plasmodium (malaria), Amoeba | Disease, research models |
| Viruses | Non-cellular | HIV, SARS-CoV-2, Influenza | Disease, gene therapy vectors |
| Prions | Protein only | BSE (mad cow), CJD | Misfolded proteins cause neurodegenerative disease |
6.2 Fermentation
Fermentation is the anaerobic metabolic conversion of organic compounds (primarily sugars) by microbes to simpler molecules with production of ATP.
Alcoholic Fermentation (yeast — Saccharomyces cerevisiae)
- Equation: C₆H₁₂O₆ → 2C₂H₅OH (ethanol) + 2CO₂ + Energy (2 ATP)
- Commercial uses: beer, wine, whisky, rum; bioethanol for fuel; bread leavening (CO₂ makes bread rise)
Lactic Acid Fermentation (bacteria — Lactobacillus spp.)
- Equation: Glucose → Lactic acid (+ energy)
- Used in: yogurt/curd (Lactobacillus bulgaricus/thermophilus), cheese, silage, kimchi, sauerkraut
Industrial Fermentation
- Penicillin: Penicillium notatum/chrysogenum — industrial scale in bioreactors
- Citric acid: Aspergillus niger — food additive
- Recombinant human insulin: E. coli expressing human insulin gene — revolutionised diabetes treatment (1982, Humulin — first recombinant protein drug)
- Biofuels: Cellulosic biomass fermentation for second-generation bioethanol
6.3 Infectious Diseases
| Disease | Pathogen | Transmission | Prevention |
|---|---|---|---|
| Tuberculosis (TB) | Mycobacterium tuberculosis | Airborne droplets | BCG vaccine; DOTS therapy |
| Malaria | Plasmodium spp. (P. falciparum most fatal) | Anopheles mosquito bite | Mosquito nets, antimalarials |
| COVID-19 | SARS-CoV-2 (coronavirus) | Airborne, droplets | COVID-19 vaccines (mRNA, adenovirus-vector, inactivated) |
| Dengue | Dengue virus (4 serotypes) | Aedes aegypti mosquito | No vaccine widely available; vector control |
| Polio | Poliovirus (3 types) | Faecal-oral route | OPV (oral) or IPV (injectable) |
| Hepatitis B | HBV (DNA virus) | Blood, sexual, mother-to-child | Recombinant HBV vaccine |
